Cancer Research Prevention Award Advances in Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Velicescu, M.
Right arrow Articles by Jones, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Velicescu, M.
Right arrow Articles by Jones, P. A.
[Cancer Research 62, 2378-2384, April 15, 2002]
© 2002 American Association for Cancer Research

Molecular Biology and Genetics

Cell Division Is Required for de Novo Methylation of CpG Islands in Bladder Cancer Cells1

Mihaela Velicescu2, Daniel J. Weisenberger2, Felicidad A. Gonzales, Yvonne C. Tsai, Carvell T. Nguyen and Peter A. Jones3

Urologic Cancer Research Laboratory, Department of Biochemistry and Molecular Biology, University of Southern California/Norris Comprehensive Cancer Center, University of Southern California, Keck School of Medicine, Los Angeles, California 90089-9181

Cell division is essential for tumor development and progression. Methylation-mediated silencing caused by aberrant de novo methylation of CpG islands located in the promoter regions of growth regulatory genes occurs frequently in human cancers. We investigated the relationship between cell division and de novo methylation to determine whether de novo methylation can occur in the absence of cell division in cancer cells. We treated T24 bladder carcinoma cells with 5-Aza-2'-deoxycytidine to induce a transient demethylation and then compared the timing and kinetics of remethylation of the p16 gene locus under conditions of either G0-G1 growth arrest induced by serum starvation and confluence or continuous cell proliferation in complete medium. Variable levels of remethylation were detected in CpG poor regions of DNA, as well as repetitive DNA elements in the absence of cell division, yet no remethylation occurred at CpG islands under these conditions. This correlated with continuous expression of p16 protein in these cells. DNA methyltransferase (DNMT)1 and DNMT3b3 proteins were undetectable in 5-Aza-2'-deoxycytidine-treated and untreated nondividing cells, and their mRNA transcripts were down-regulated in these cells. Although DNMT3a mRNA levels were also reduced, they recovered to original levels in nondividing cells after drug treatment. Our results suggest that cell division is required for de novo methylation of CpG islands and that DNMT3a may play a role in methylating CpG poor regions or repetitive DNA elements outside of the S phase of the cell cycle.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
K. D. Siegmund, P. Marjoram, Y.-J. Woo, S. Tavare, and D. Shibata
Inferring clonal expansion and cancer stem cell dynamics from DNA methylation patterns in colorectal cancers
PNAS, March 24, 2009; 106(12): 4828 - 4833.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
L.-P. Wu, X. Wang, L. Li, Y. Zhao, S. Lu, Y. Yu, W. Zhou, X. Liu, J. Yang, Z. Zheng, et al.
Histone Deacetylase Inhibitor Depsipeptide Activates Silenced Genes through Decreasing both CpG and H3K9 Methylation on the Promoter
Mol. Cell. Biol., May 15, 2008; 28(10): 3219 - 3235.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. Zighelboim, P. J. Goodfellow, A. P. Schmidt, K. C. Walls, M. A. Mallon, D. G. Mutch, P. S. Yan, T. H.-M. Huang, and M. A. Powell
Differential Methylation Hybridization Array of Endometrial Cancers Reveals Two Novel Cancer-Specific Methylation Markers
Clin. Cancer Res., May 15, 2007; 13(10): 2882 - 2889.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
J. Tan, X. Yang, L. Zhuang, X. Jiang, W. Chen, P. L. Lee, R.K. M. Karuturi, P. B. O. Tan, E. T. Liu, and Q. Yu
Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
Genes & Dev., May 1, 2007; 21(9): 1050 - 1063.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
Z. Herceg
Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors
Mutagenesis, March 1, 2007; 22(2): 91 - 103.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Maekita, K. Nakazawa, M. Mihara, T. Nakajima, K. Yanaoka, M. Iguchi, K. Arii, A. Kaneda, T. Tsukamoto, M. Tatematsu, et al.
High Levels of Aberrant DNA Methylation in Helicobacter pylori-Infected Gastric Mucosae and its Possible Association with Gastric Cancer Risk
Clin. Cancer Res., February 1, 2006; 12(3): 989 - 995.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
F. Lyko and R. Brown
DNA Methyltransferase Inhibitors and the Development of Epigenetic Cancer Therapies
J Natl Cancer Inst, October 19, 2005; 97(20): 1498 - 1506.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
Q. Zhang, J. N. Rubenstein, T. L. Jang, M. Pins, B. Javonovic, X. Yang, S.-J. Kim, I. Park, and C. Lee
Insensitivity to Transforming Growth Factor-{beta} Results from Promoter Methylation of Cognate Receptors in Human Prostate Cancer Cells (LNCaP)
Mol. Endocrinol., September 1, 2005; 19(9): 2390 - 2399.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Pantoja, L. de los Rios, A. Matheu, F. Antequera, and M. Serrano
Inactivation of Imprinted Genes Induced by Cellular Stress and Tumorigenesis
Cancer Res., January 1, 2005; 65(1): 26 - 33.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
A. H. Lund and M. van Lohuizen
Epigenetics and cancer
Genes & Dev., October 1, 2004; 18(19): 2315 - 2335.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Suzuki, N. Sunaga, D. S. Shames, S. Toyooka, A. F. Gazdar, and J. D. Minna
RNA Interference-Mediated Knockdown of DNA Methyltransferase 1 Leads to Promoter Demethylation and Gene Re-Expression in Human Lung and Breast Cancer Cells
Cancer Res., May 1, 2004; 64(9): 3137 - 3143.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. C. Cheng, D. J. Weisenberger, F. A. Gonzales, G. Liang, G.-L. Xu, Y.-G. Hu, V. E. Marquez, and P. A. Jones
Continuous Zebularine Treatment Effectively Sustains Demethylation in Human Bladder Cancer Cells
Mol. Cell. Biol., February 1, 2004; 24(3): 1270 - 1278.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
D. J. Weisenberger, M. Velicescu, J. C. Cheng, F. A. Gonzales, G. Liang, and P. A. Jones
Role of the DNA Methyltransferase Variant DNMT3b3 in DNA Methylation
Mol. Cancer Res., January 1, 2004; 2(1): 62 - 72.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J.-P. J. Issa
Methylation and Prognosis: Of Molecular Clocks and Hypermethylator Phenotypes
Clin. Cancer Res., August 1, 2003; 9(8): 2879 - 2881.
[Full Text] [PDF]

Home page
 Eukaryot CellHome page
H. S. Judelson and S. Roberts
Novel Protein Kinase Induced during Sporangial Cleavage in the Oomycete Phytophthora infestans
Eukaryot. Cell, October 1, 2002; 1(5): 687 - 695.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.